Terms: = Leukemia AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
10 results:
1. Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid leukemia.
Daull AM; Dubois V; Labussière-Wallet H; Venet F; Barraco F; Ducastelle-Lepretre S; Larcher MV; Balsat M; Gilis L; Fossard G; Ghesquières H; Heiblig M; Ader F; Alcazer V
Front Immunol; 2022; 13():841470. PubMed ID: 35309346
[TBL] [Abstract] [Full Text] [Related]
2. A revised international prognostic score system for Waldenström's macroglobulinemia.
Kastritis E; Morel P; Duhamel A; Gavriatopoulou M; Kyrtsonis MC; Durot E; Symeonidis A; Laribi K; Hatjiharissi E; Ysebaert L; Vassou A; Giannakoulas N; Merlini G; Repousis P; Varettoni M; Michalis E; Hivert B; Michail M; Katodritou E; Terpos E; Leblond V; Dimopoulos MA
Leukemia; 2019 Nov; 33(11):2654-2661. PubMed ID: 31118465
[TBL] [Abstract] [Full Text] [Related]
3. CD45 correlates with adverse risk stratification, decreased treatment response and unfavorable survival profiles in elderly acute myeloid leukemia patients.
Guo L; Chen L; Wang H
Cancer Biomark; 2018; 23(3):455-463. PubMed ID: 30347598
[TBL] [Abstract] [Full Text] [Related]
4. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid leukemia.
Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy.
Choi JE; Kang SH; Lee SJ; Bae YK
Tumour Biol; 2014 Dec; 35(12):12255-63. PubMed ID: 25179840
[TBL] [Abstract] [Full Text] [Related]
6. Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.
Rozman M; Navarro JT; Arenillas L; Aventín A; Giménez T; Alonso E; Perea G; Camós M; Navarrete M; Tuset E; Florensa L; Millá F; Nomdedéu J; de la Banda E; Díaz-Beyá M; Pratcorona M; Garrido A; Navarro B; Brunet S; Sierra J; Esteve J;
Ann Hematol; 2014 Oct; 93(10):1695-703. PubMed ID: 24824767
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of multicenter efficacy of acute lymphoblastic leukemia in older children].
Jiang H; Tang JY; Zhang N; Sun LR; Yuan XJ; Wang NL
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):581-6. PubMed ID: 23906450
[TBL] [Abstract] [Full Text] [Related]
8. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.
Vay A; Kumar S; Seward S; Semaan A; Schiffer CA; Munkarah AR; Morris RT
Gynecol Oncol; 2011 Dec; 123(3):456-60. PubMed ID: 21855120
[TBL] [Abstract] [Full Text] [Related]
9. [Relationship between the long type PML-RAR alpha and the prognosis of patients with acute promyelocytic leukemia].
Tan YH; Wang HW; Zhang ZP; Liu W; Guo HM; Zhu L; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):44-7. PubMed ID: 18512315
[TBL] [Abstract] [Full Text] [Related]
10. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
Xing W; Gu BW; Zhu YM; Jiang CL; Zhao RH; Wang AH; Sun HP; Li JM; Shen ZX; Chen Z; Chen SJ
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):453-7. PubMed ID: 15854550
[TBL] [Abstract] [Full Text] [Related]
